Compliance, clinical outcome, and quality of life of patients with stable angina pectoris receiving once-daily betaxolol versus twice daily metoprolol: a randomized controlled trial (Q36013094)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Compliance, clinical outcome, and quality of life of patients with stable angina pectoris receiving once-daily betaxolol versus twice daily metoprolol: a randomized controlled trial	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

11 August 2017

Compliance, clinical outcome, and quality of life of patients with stable angina pectoris receiving once-daily betaxolol versus twice daily metoprolol: a randomized controlled trial (English)

1 reference

Europe PubMed Central

11 August 2017

1 reference

based on heuristic

inferred from title

Przemysław Kardas

1

object named as

Przemyslaw Kardas

1 reference

Europe PubMed Central

11 August 2017

language of work or name

0 references

publication date

1 January 2007

1 reference

Europe PubMed Central

11 August 2017

Vascular Health and Risk Management

1 reference

Europe PubMed Central

11 August 2017

3

1 reference

Europe PubMed Central

11 August 2017

2

1 reference

Europe PubMed Central

11 August 2017

235-242

1 reference

Europe PubMed Central

11 August 2017

Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1994030

2 October 2017

Patient adherence to prescribed antimicrobial drug dosing regimens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1994030

2 October 2017

Association of medication adherence, knowledge, and skills with emergency department visits by adults 50 years or older with congestive heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1994030

2 October 2017

Effect of partial compliance on cardiovascular medication effectiveness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1994030

2 October 2017

Patient non-compliance with paper diaries

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1994030

2 October 2017

The impact of non-compliance on the cost-effectiveness of pharmaceuticals: a review of the literature.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1994030

2 October 2017

Drug related medical emergencies in the elderly: role of adverse drug reactions and non-compliance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1994030

2 October 2017

A systematic review of the associations between dose regimens and medication compliance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1994030

2 October 2017

EQ-5D: a measure of health status from the EuroQol Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1994030

2 October 2017

The effect of beta-blockers on health-related quality of life in patients with heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1994030

2 October 2017

Double-blind comparison of once daily betaxolol versus propranolol four times daily in stable angina pectoris. Betaxolol Investigators Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1994030

11 July 2018

Treatment adherence and risk of death after a myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1994030

11 July 2018

Impact of diagnosis and treatment of hypertension on quality of life: a double-blind, randomized, placebo-controlled, cross-over study of betaxolol.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1994030

11 July 2018

The DIACOM study (effect of DosIng frequency of oral Antidiabetic agents on the COMpliance and biochemical control of type 2 diabetes).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1994030

23 September 2018

Betaxolol is equivalent to carvedilol in patients with heart failure NYHA II or III: result of a randomized multicenter trial (BETACAR Trial).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1994030

23 September 2018

Comparison of once daily versus twice daily oral nitrates in stable angina pectoris

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1994030

23 September 2018

Compliance and optimisation of oral antidiabetic therapy. A longitudinal study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1994030

23 September 2018

Monotoring adherence to prescribed medication in type 2 diabetic patients treated with sulfonylureas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1994030

23 September 2018

Beta-blockers in heart failure. Do they improve the quality as well as the quantity of life?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1994030

23 September 2018

Relationship between the prescriber's instructions and compliance with antibiotherapy in outpatients treated for an acute infectious disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1994030

23 September 2018

Patient compliance and therapeutic coverage: amlodipine versus nifedipine (slow-release) in the treatment of angina pectoris. Belgian Collaborative Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1994030

23 September 2018

Use and adherence to beta-blockers for secondary prevention of myocardial infarction: who is not getting the treatment?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1994030

14 November 2018

Efficacy of betaxolol in the treatment of stable exertional angina pectoris: a dose-ranging study

1 reference

https://api.crossref.org/works/10.2147%2FVHRM.2007.3.2.235

31 March 2020

Patient compliance with once-daily and twice-daily oral formulations of 5-isosorbide mononitrate: a comparative study

1 reference

https://api.crossref.org/works/10.2147%2FVHRM.2007.3.2.235

31 March 2020

Betaxolol in the treatment of stable angina pectoris

1 reference

https://api.crossref.org/works/10.2147%2FVHRM.2007.3.2.235

31 March 2020

[Effect of bisoprolol, a beta 1-selective beta-blocker, on lipid and glucose metabolism and quality of life in elderly patients with essential hypertension]

1 reference

https://api.crossref.org/works/10.2147%2FVHRM.2007.3.2.235

31 March 2020

Helping patients follow prescribed treatment: clinical applications

1 reference

https://api.crossref.org/works/10.2147%2FVHRM.2007.3.2.235

31 March 2020

A Study Design for Comparing the Effects of Missing Daily Doses of Antihypertensive Drugs

1 reference

https://api.crossref.org/works/10.2147%2FVHRM.2007.3.2.235

31 March 2020

Twenty-four-hour beta-blockade in stable angina pectoris: a study of atenolol and betaxolol

1 reference

https://api.crossref.org/works/10.2147%2FVHRM.2007.3.2.235

31 March 2020

The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers

1 reference

https://api.crossref.org/works/10.2147%2FVHRM.2007.3.2.235

31 March 2020

Effectiveness of interventions to improve patient compliance: a meta-analysis

1 reference

https://api.crossref.org/works/10.2147%2FVHRM.2007.3.2.235

31 March 2020

[Time of drug intake in hypertension and angina pectoris. A controlled monitoring study]

1 reference

https://pubmed.ncbi.nlm.nih.gov/17580734

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A study of efficacy, tolerance and compliance of once-daily versus twice-daily metoprolol (Betaloc) in hypertension. Betaloc Compliance Canadian Cooperative Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17580734

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2147/VHRM.2007.3.2.235

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36013094&oldid=1980227930"